Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
XTNT
HoldUnloved QualityXtant Medical Holdings, Inc. · Healthcare · United States · $54M · Avg Vol: $1M/d
44
StockRankGet insider-trade alerts
Q
62
V
53
M
23
P/E (TTM)
—
ROE
-25.2%
D/E
0.7x
Dividend %
—
COMPANY DESCRIPTION
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58.0M | 91.3M | 117.3M | 133.9M | 32.2% | 109.5M | 99.4M | 110.2M | -9.3% |
| EPS | -0.09 | 0.01 | -0.12 | 0.04 | 100.0% | -0.08 | -0.08 | -0.03 | — |
| Shares | 108.9M | 130.2M | 139.0M | 140.0M | +28.6% | 140.3M | — | — | — |
| Debt | 17.1M | 23.6M | 35.1M | 28.7M | 18.9% | 26.0M | — | — | — |
| Equity | 34.2M | 51.3M | 43.0M | 51.0M | 14.2% | — | — | — | — |
| Op CF | -5.3M | -9.5M | -11.9M | 12.5M | — | — | — | — | — |
| Inv CF | -1.6M | -24.8M | -3.7M | 7.9M | — | — | — | — | — |
| Fin CF | 9.0M | 19.7M | 16.1M | -9.6M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-9.3%
SMA 50SMA 200
Close
$0.3898
RSI (14)
66.6
52W High
$0.95
From 52W High
0.4%
SCORE BREAKDOWN
Quality
62
ROIC
11.0%73.9
ROE
-25.2%28.2
GP/Assets
69.1%94.0
Op. Margin
-18.1%25.4
FCF/Assets
8.3%82.0
Piotroski
894.2
Int. Cover
2.2x43.1
D/E Ratio
0.65x22.5
Current Ratio
2.16x42.1
Value
53
P/E (TTM)
—N/A
EV/EBITDA
-46.7x25.0
P/FCF
6.9x90.4
P/B
1.3x78.1
P/S
0.5x93.2
Div Yield
—N/A
Momentum
23
52W High %
41%14.7
RS 6M
-51%12.9
SMA 50/200
0.75x10.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+63%62.0
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$54M
P/E (Forward)
-12.5x
Gross Margin
59.4%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of XTNT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| XTNT | Xtant Medical Holdings, Inc.(you) | $54M | 44 | Hold |
| SNWV | SANUWAVE Health, Inc. | $51M | 47 | Hold |
| MYO | Myomo, Inc. | $63M | 34 | Sell |
| INGN | Inogen, Inc. | $146M | 46 | Hold |
| ECOR | electroCore, Inc. | $87M | 32 | Sell |
| SRTS | Sensus Healthcare, Inc. | $58M | 22 | Sell |
| ARAY | Accuray Incorporated | $53M | 19 | Strong Sell |
| OM | Outset Medical, Inc. | $74M | 24 | Sell |
| LUNG | Pulmonx Corporation | $102M | 29 | Sell |
| MXCT | MaxCyte, Inc. | $126M | 32 | Sell |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.1%